TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Lundbeck Pharma A/S
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2020/12 |
| Turnover |
15,968
|
16,955
|
19,163 |
| Earnings before taxes |
2,171
|
2,162
|
-4,367 |
| Total assets |
16,719
|
12,598
|
14,078 |
| Current assets |
16,558
|
12,047
|
13,485 |
| Current liabilities |
14,184
|
10,278
|
15,678 |
| Equity capital |
2,535
|
4,640
|
-1,600 |
| - share capital |
500
|
500
|
500 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2020/12 |
| Solvency |
15.2%
|
36.8%
|
-11.4% |
| Turnover per employee |
1,065
|
1,130
|
1,278 |
| Profit as a percentage of turnover |
13.6%
|
12.8%
|
-22.8% |
| Return on assets (ROA) | |||
| Current ratio |
116.7%
|
117.2%
|
86.0% |
| Return on equity (ROE) |
85.6%
|
46.6%
|
272.9% |
| Change turnover |
-987
|
-2,208
|
1,876 |
| Change turnover % |
-6%
|
-12%
|
11% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.